AnalystsYun ZhongYun Zhong's Stock Forecasts
AnalystsYun Zhong
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#4889 out of 4906 analysts
Average Return
-32.53%
Win Rate
24%8 out of 34
Risk vs Reward
Poor
Good
Yun Zhong's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tectonic Therapeutic IncTECX | +77.07% | $9.42 | $16.68 | 2022-12-07 - 2023-12-07 | Strong Buy |
Nightstar Therapeutics PLCNITE1 | +31.32% | $19.35 | $25.41 | 2018-08-21 - 2019-06-07 | Strong Buy |
Dianthus Therapeutics IncDNTH | +31.03% | $5.80 | $7.60 | 2022-12-20 - 2023-12-20 | Strong Buy |
Sarepta Therapeutics IncSRPT | +26.65% | $132.05 | $167.24 | 2019-12-12 - 2020-12-11 | Strong Buy |
Protagonist Therapeutics IncPTGX | +22.81% | $45.90 | $56.37 | 2024-11-04 - 2025-06-13 | Buy |
Yun Zhong Analyst Color
Get additional color on Yun Zhong's coverage of popular stocks
Yun Zhong's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Keros Therapeutics IncKROS | 2 | Hold | $15.00 | +10.62% | Reiterates | 16 days ago |
Camp4 Therapeutics CorpCAMP | 1 | Buy | $8.00 | +419.48% | Initiates Coverage On | 19 days ago |
Rocket Pharmaceuticals IncRCKT | 2 | Buy | $32.00 | +992.15% | Reiterates | a month ago |
Ascendis Pharma AASND | 1 | Buy | $212.00 | +24.12% | Maintains | a month ago |
Protagonist Therapeutics IncPTGX | 2 | Buy | $70.00 | +24.18% | Reiterates | 3 months ago |
Passage Bio IncPASG | 2 | Buy | $4.00 | +923.02% | Assumes | 7 months ago |
Moonlake ImmunotherapeuticsMLTX | 1 | Buy | $73.00 | +65.12% | Assumes | 7 months ago |
Rezolute IncRZLT | 1 | Buy | $12.00 | +185.71% | Initiates Coverage On | 7 months ago |
Anavex Life Sciences CorpAVXL | 2 | Strong Buy | $28.00 | N/A | Maintains | 2 years ago |
Amicus Therapeutics IncFOLD | 1 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Sarepta Therapeutics IncSRPT | 4 | Strong Buy | $160.00 | N/A | Maintains | 2 years ago |
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $3.00 | N/A | Maintains | 2 years ago |
Tectonic Therapeutic IncTECX | 2 | Strong Buy | $48.00 | N/A | Upgrades | 3 years ago |
Applied Genetic Technologies CorpAGTC | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Renovacor IncRCOR | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Freeline Therapeutics Holdings PLCFRLN | 2 | Strong Buy | $75.00 | N/A | Maintains | 3 years ago |
Lenz Therapeutics IncLENZ | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Bluebird Bio IncBLUE | 2 | Hold | $700.00 | N/A | Downgrades | 4 years ago |
Uniqure NvQURE | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 4 years ago |
Cartesian Therapeutics IncRNAC | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 4 years ago |
Sio Gene Therapies IncSIOX | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 4 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $44.00 | N/A | Initiates Coverage On | 4 years ago |
Mereo Biopharma Group PLCMREO | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 4 years ago |
Nightstar Therapeutics PLCNITE1 | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.